Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor
- 1 February 2003
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 461 (2-3) , 99-104
- https://doi.org/10.1016/s0014-2999(03)01310-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Modification of a commercial chiral stationary phaseJournal of Chromatography A, 2001
- Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depressionJournal of Affective Disorders, 2000
- The role of dopamine in the mechanism of action of antidepressant drugsEuropean Journal of Pharmacology, 2000
- Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatmentsMolecular Psychiatry, 2000
- Comparison of pramipexole, fluoxetine, and placebo in patients with major depressionDepression and Anxiety, 2000
- SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depressionThe Lancet, 2000
- Effect of antidepressant drugs on dopamine D 1 and D 2 receptor expression and dopamine release in the nucleus accumbens of the ratPsychopharmacology, 1998
- Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)Pharmacology Biochemistry and Behavior, 1995
- Is the forced swimming test a suitable model for revealing antidepressant activity?Psychopharmacology, 1988